Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ulrike Loeber"'
Autor:
Marc Schoeler, Sandrine Ellero-Simatos, Till Birkner, Jordi Mayneris-Perxachs, Lisa Olsson, Harald Brolin, Ulrike Loeber, Jamie D. Kraft, Arnaud Polizzi, Marian Martí-Navas, Josep Puig, Antonio Moschetta, Alexandra Montagner, Pierre Gourdy, Christophe Heymes, Hervé Guillou, Valentina Tremaroli, José Manuel Fernández-Real, Sofia K. Forslund, Remy Burcelin, Robert Caesar
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Dietary lipids can affect metabolic health through gut microbiota-mediated mechanisms, but the influence of lipid-microbiota interaction on liver steatosis is largely unknown. We investigate the impact of dietary lipids on human gut microbio
Externí odkaz:
https://doaj.org/article/b3b8887947dd4c14b3e0120418bffa47
Autor:
Bastian Opitz, Patrick Dörner, Harithaa Anandakumar, Ivo Röwekamp, Miha Milek, Facundo Fiocca Vernengo, Belen Millet Pascual-Leone, Marta Krzanowski, Vanessa Igbokwe, Ulrike Loeber, Markus Holstein, Gitta Heinz, Mir-Farzin Mashreghi, Leon Schulte, Ann-Brit Klatt, Sandra Caesar, Sandra-Maria Wienhold, Stefan Offermanns, Matthias Mack, Martin Witzenrath, Dieter Beule, Sofia Forslund, Nicola Wilck, Hendrik Bartolomaeus, Markus Heimesaat
Hospital-acquired pneumonia (HAP) is associated with high mortality and costs, and frequently caused by multidrug-resistant (MDR) bacteria. Although prior antimicrobial therapy is a major risk factor for HAP, the underlying mechanism remains incomple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a18ad8e12ff68d6b6122a69c73002b03
https://doi.org/10.21203/rs.3.rs-2873449/v1
https://doi.org/10.21203/rs.3.rs-2873449/v1
Autor:
Hendrik Bartolomaeus, Johannes Holle, Ulrike Loeber, Felix Behrens, Theda Bartolomaeus, Harithaa Anandakumar, Moritz I Wimmer, Dai Long Vu, Sabrina Y Geisberger, Kai-Uwe Eckardt, Sofia Kirke Forslund, Andrea Thürmer, Victoria McParland, Jennifer A Kirwan, Dominik Müller, Nicola Wilck
Publikováno v:
Hypertension. 79
Introduction: Chronic inflammation is a major risk factor for cardiovascular disease in chronic kidney disease (CKD). The underlying mechanisms are incompletely understood, but may be linked to gut dysbiosis. We aim to describe the microbiota-immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ce0bc50a4850d303edf1262e85f5870
https://doi.org/10.1161/hyp.79.suppl_1.013
https://doi.org/10.1161/hyp.79.suppl_1.013
Autor:
Moritz I Wimmer, Hendrik Bartolomaeus, Chia-Yu Chen, Sarah Kedziora, Valentin Vecera, Olena Potapenko, Theda Bartolomaeus, Victor H Jarquindiaz, Ulrike Loeber, Nadine Haase, Sofia Kirke Forslund, Dominik N Mueller, Nicola Wilck
Publikováno v:
Hypertension. 79
Introduction: Metformin (Met) is used as a first-line treatment in type II diabetes, reduces the cardiovascular (CV) risk in diabetes and may lead to decreased CV mortality independent of diabetes status. Met treatment has been shown to induce gut mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebba7e7099088573e4d3534edb9f777b
https://doi.org/10.1161/hyp.79.suppl_1.p087
https://doi.org/10.1161/hyp.79.suppl_1.p087
Autor:
Tisya Banerjee, Camille V. Goemans, Elisabetta Cacace, Exene Erin Anderson, Lisa A. Maier, Sofia K. Forslund, Mihaela Pruteanu, Michael Kuhn, Athanasios Typas, Jakob Wirbel, Kiran Raosaheb Patil, Georg Zeller, Alessio Milanese, Ulrike Loeber, Peer Bork
Antibiotics are used for fighting pathogens, but also target our commensal bacteria as a side effect, disturbing the gut microbiota composition and causing dysbiosis and disease1-3. Despite this well-known collateral damage, the activity spectrum of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3129571da1c3c98cdcc57905bdf40dbb
https://doi.org/10.1101/2020.01.09.893560
https://doi.org/10.1101/2020.01.09.893560